The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket ...
The U.S. government will be releasing a preliminary list of generic drugs that would be made available to recipients of the Medicare program for no more than $2, Axios reported on Wednesday citing U.S ...
The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make ...
The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Antimicrobial resistance (AMR) bacterial infections have become a serious problem threatening human health worldwide. The ...
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
1. Under the model, individuals enrolled in participating Medicare Part D plans would pay no more than $2 for a month's supply of each drug included on the list. The model aims to standardize low ...